112293 ⎘
Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING
#2Lentiviral Vectors
#3GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES
#4COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION
#5GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES
#6TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING
#7TRANSGENIC MICE
#8MAMMALIAN EXPRESSION VECTORS
#9Compositions and methods for enhanced gene expression in cone cells
#10AUGMENTATIONS TO LENTIVIRAL VECTORS (CCLC-MGATA/ANK-CORE LCR-BETA-AS3-FB) TO INCREASE EXPRESSION
#11TRANSCRIPTIONAL REGULATORY ELEMENT AND ITS USE IN ENHANCING THE EXPRESSION OF HETEROLOGOUS PROTEIN
#12Production of soluble recombinant proteins without N-terminal methionine in
#13Transcriptional regulatory element and its use in enhancing the expression of heterologous protein
#14RIBONUCLEOPROTEIN TRANSFECTION AGENTS
#15Globin gene therapy for treating hemoglobinopathies
#16Compositions comprising AAV expressing dual antibody constructs and uses thereof
#17DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING A PRO-APOPTOTIC PROTEIN
#18INTEGRATION OF MESA RECEPTORS AND PROMOTORS TO IMPLEMENT CUSTOMIZED CELLULAR FUNCTION
#19Compositions comprising AAV expressing dual antibody constructs and uses thereof
#20CHIMERIC POST-TRANSCRIPTIONAL REGULATORY ELEMENT
#21SPATIOTEMPORAL REGULATORS
#22Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer
#23Expression and purification of CRM proteins and related proteins, and protein domains
#24Compositions comprising AAV expressing dual antibody constructs and uses thereof
#25Reporter system for detecting and targeting activated cells
#26Transgenic mice
#27Cell populations, methods of transdifferentiation and methods of use thereof
#28Methods and compositions for integration defective lentiviral vectors
#29Compositions and methods for enhanced gene expression in cone cells
#30Method for expression of small RNA molecules within a cell
#31Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
#32Compositions and methods for enhancing gene expression
#33Compositions and method for reducing seizures
#34Optimized expression cassette for expressing a polypeptide with high yield
#35Globin gene therapy for treating hemoglobinopathies
#36Chimeric post-transcriptional regulatory element
#37Ribonucleoprotein transfection agents
#38Compositions comprising AAV expressing dual antibody constructs and uses thereof
#39METHODS AND COMPOSITIONS RELATING TO RESTRICTED EXPRESSION LENTIVIRAL VECTORS AND THEIR APPLICATIONS
#40Super-enhancers and methods of use thereof
#41Optimized expression cassette for expressing a polypeptide with high yield
#42Artificial DNA sequence with optimized leader function in 5′(5′-UTR) for the over-expression of recombinant proteins in plants and method for the production of recombinant proteins in plants
#43Cell populations, methods of transdifferentiation and methods of use thereof
#44Baculoviral DNA elements for the expression of recombinant proteins in a host cell
#45Compositions and methods for enhanced gene expression in cone cells
#46Method for expression of small RNA molecules within a cell
#47MATERIALS AND METHODS FOR MAKING A RECESSIVE GENE DOMINANT
#48Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence
#49Methods and compositions relating to restricted expression lentiviral vectors and their applications
#50Genetic element that enhances protein translation
#51REIC-expressing adenovirus vector
#52Nucleic acids encoding FOXD3 promoter and methods to isolate FOXD3 expressing cells
#53Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#54Cardiac-specific nucleic acid regulatory elements and methods and use thereof
#55Method of expression of foreign gene in plant induced by chemical substance
#56PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#57Bovine immunodeficiency virus (BIV) based vectors
#58Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#59Method for expression of small RNA molecules within a cell
#60TRANSGENIC RABBITS PRODUCING HUMAN FACTOR VII
#61STEM CELL EXPRESSION CASSETTES
#62Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells
#63Genetically modified animal for use in evaluating harmfulness of test substance
#64Methods for expression of transgenes
#65Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#66Expression system incorporating a capsid promoter sequence as an enhancer
#67REGULATORY ELEMENTS THAT MEDIATE RETINAL CELL-SPECIFIC GENE EXPRESSION
#68ENRICHED PREPARATION OF HUMAN FETAL MULTIPOTENTIAL NEURAL STEM CELLS
#69HBM variants that modulate bone mass and lipid levels
#70Bovine immunodeficiency virus (BIV) based vectors
#71TRANSGENIC ORGANISM
#72Preprotachykinin Enhancer Elements
#73Method for expression of small antiviral RNA molecules within a cell
#74Treatment of diabetes with synthetic beta cells
#75Bovine immunodeficiency virus (BIV) based vectors
#76Methods and compositions relating to restricted expression lentiviral vectors and their applications
#77Methods for modulating apoptotic cell death
#78Human prolyl isomerase 1 (PIN 1) promoter and uses thereof
#79Pluripotent cells with improved efficiency of homologous recombination and use of the same
#80Highly hypoxia-specific gene expression system for ischemic gene therapy
#81Nuclear factors associated with transcriptional regulation
#82Bovine immunodeficiency virus (BIV) based vectors
#83Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
#84Hepatitis C virus nonstructural protein 4A (NS4A) is an enhancer element
#85Control of gene expression in eukaryotic cells
#86Bovine immunodeficiency virus (BIV) based vectors
#87Modulators of morphogen expression and methods of identifying the same
#88Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#89Bovine immunodeficiency virus (BIV) based vectors
#90Bovine immunodeficiency virus (BIV) based vectors
#91HBM variants that modulate bone mass and lipid levels
#92Methods and compositions for rapid development of screening assays